Ubs Asset Management Americas Inc Blueprint Medicines Corp Transaction History
Ubs Asset Management Americas Inc
- $381 Billion
- Q3 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 227,911 shares of BPMC stock, worth $20.6 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
227,911
Previous 301,873
24.5%
Holding current value
$20.6 Million
Previous $32.5 Million
35.23%
% of portfolio
0.01%
Previous 0.01%
Shares
28 transactions
Others Institutions Holding BPMC
# of Institutions
351Shares Held
60.3MCall Options Held
2.25MPut Options Held
1.18M-
Vanguard Group Inc Valley Forge, PA6.68MShares$605 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$601 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$487 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA3.96MShares$359 Million0.07% of portfolio
-
State Street Corp Boston, MA2.77MShares$250 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.4B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...